Amycolatopsis azurea Details: NCBI 36819, high G+C gram-positive [species]

| Amycolatopsis azurea| Amycolatopsis azurea (Omura et al. 1983) Henssen et al. 1987| ATCC 51273| DSM 43854| FERM P 4738| IFO 14573| IMSNU 20053| JCM 3275| NBRC 14573| NRRL 11412| Pseudonocardia azurea| Pseudonocardia azurea Omura et al. 1983| strain AM-3696| VKM Ac-1418

  1. Antibiotic Production: Amycolatopsis species are known for their ability to produce a wide range of bioactive compounds, including antibiotics with potential therapeutic applications. These antibiotics may have antimicrobial, antifungal, or antiparasitic properties and may be used in medicine, agriculture, or industry.

  2. Environmental Role: Amycolatopsis species are commonly found in soil and other environmental habitats, where they play important roles in organic matter decomposition, nutrient cycling, and soil ecology. They contribute to soil health and fertility by breaking down organic materials and recycling nutrients.

  3. Rare Infections: While Amycolatopsis species are generally considered non-pathogenic to humans, there have been rare reports of infections associated with these bacteria, particularly in immunocompromised individuals or those with underlying medical conditions. These infections are typically opportunistic and may manifest as localized infections, abscesses, or systemic infections.

  4. Biotechnological Applications: Amycolatopsis species, including Amycolatopsis azurea, have significant biotechnological potential due to their ability to produce bioactive compounds with diverse pharmacological properties. These bacteria are widely studied for their potential applications in drug discovery, bioremediation, agriculture, and industrial biotechnology.

Visuals of Interactions with other bacteria of the same rank

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Amycolatopsis azurea

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.13 19 28 14 32 23 22 4.6 19 28 0 %ile 100 %ile
thryve 0.27 19 28 14 32 23 22 4.6 19 28 20 %ile 60 %ile

External Reference Ranges for Amycolatopsis azurea

Amycolatopsis azurea (NCBI 36819) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Amycolatopsis azurea
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
Thryve 0.259 %   0.002 %  0 % 4.0 1543

To see medical conditions associated you may be logged in

And display level must be raised above public.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]